Indoco Remedies Limited (NSE:INDOCO)

India · Delayed Price · Currency is INR

210.19

+0.53 (0.25%)

Jun 1, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	18.45B	16.65B	18.17B	16.69B	15.41B
Pharmaceuticals Growth	10.84%	-8.38%	8.91%	8.30%	24.10%
Total	18.45B	16.65B	18.17B	16.69B	15.41B
Total Growth	10.84%	-8.38%	8.91%	8.30%	24.10%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	11.24B	10.90B	9.68B	8.50B	8.47B
India Growth	3.09%	12.69%	13.86%	0.29%	25.34%
Outside India	6.69B	5.51B	8.21B	7.90B	6.56B
Outside India Growth	21.41%	-32.87%	3.84%	20.38%	20.97%
Total	17.93B	16.41B	17.88B	16.40B	15.04B
Total Growth	9.24%	-8.22%	9.03%	9.06%	23.40%

Source: S&P Global Market Intelligence.